Endometrial Ablation Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Endometrial Ablation Devices Market is segmented By Device Type (Hydrothermal ablators, Thermal balloon ablators, Hysteroscopy devices, Cryoablation devices, Radiofrequency endometrial ablation devices, Microwave endometrial ablators, Electrical ablators, Others), By End-User (Hospitals, Ambulatory surgical centers, Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Endometrial Ablation Devices Market Size

The global endometrial ablation device market reached US$ 3.5 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 5.4 billion by 2031. The global endometrial ablation devices market is expected to exhibit a CAGR of 5.6% during the forecast period (2024-2031).

Endometrial ablation devices are useful instruments in the treatment of a variety of disorders affecting the endometrium, the uterine inner lining. Endometrial ablation is a minimally invasive surgery aimed at removing or destroying endometrial tissue in order to minimise or halt irregular uterine bleeding. Endometrial ablation is a procedure used to treat excessive menstrual blood loss. Endometrial ablation is required when a woman has very heavy periods, which are commonly characterised as soaking a pad or tampon every two hours or fewer.

Furthermore, the endometrial ablation devices market is driven by various factors like an increase in the prevalence of gynaecological disorders, frequent product launches by various market players,  technological advancements and the advantages of endometrial ablation over surgical methods.

Endometrial Ablation Devices Market Scope

For More Insights - Request Free Sample

Endometrial Ablation Devices Market Dynamics

Rising Prevalence of Gynaecological Disorders

The major factor attributing to the growth of the market is the increase in the prevalence of gynaecological disorders in women, like cervical cancer, menorrhagia, abnormal vaginal bleeding, and PCOD, or polycystic ovarian disease. For instance, according to the American Society of Clinical Oncology, in 2023, an estimated 13,960 women in the United States will be diagnosed with invasive cervical cancer. Worldwide, an estimated 604,127 women were diagnosed with cervical cancer in 2020.

It is estimated that 4,310 deaths from this disease will occur in the United States in 2023. Similar to the incidence rates, the death rate in the United States dropped by around 50% since the mid-1970s, partly because the increase in screening resulted in earlier detection of cervical cancer. However, the death rate is 65% higher in Black women than in White women, even though both groups self-report similar screening efforts. The death rate has been declining by less than 1% each year since the early 2000s. In 2020, an estimated 341,831 women worldwide died from cervical cancer.

Surge in Demand For Minimally Invasive Procedures

Endometrial ablation uses minimally invasive treatments to lessen the need for big incisions and the overall stress on the patient. Rather than creating a big abdominal incision, some treatments entail accessing the uterus through smaller incisions such as the vagina and cervix. Since endometrial cancer patients are frequently morbidly obese, effective minimally invasive surgery will almost surely minimise postoperative wound problems and will almost certainly reduce other postoperative morbidities due to speedier healing and resumption of regular daily activities.

Side Effects Associated With Endometrial Ablation

The most frequent adverse effects of endometrial ablation include discomfort, cramps, nausea, and vaginal discharge/bleeding/spotting during or shortly following the surgery. People can also get temporary diarrhoea or a headache. It also contains side effects such as fever, chills, acute cramping or stomach discomfort, excessive bleeding, continuous bleeding for more than 2 days following the treatment, and difficulty passing urine.

Endometrial Ablation Devices Market Segment Analysis

The global endometrial ablation devices are segmented based on device type, end user and region

Owing to Prevalence, the Radio Frequency Endometrial Ablation Device  Segment Accounted for Approximately 35.7% of the Endometrial Ablation Devices Share

The radio-frequency endometrial ablation device from the device type segment with around 35.7% is expected to dominate during the forecast period. Radio-frequency endometrial ablation is a surgical procedure that employs radio-frequency radiation to thin the lining of your uterus (womb). Most women report a decrease in their periods after the procedure, and for some, periods end entirely.

Radio-frequency endometrial ablation is commonly performed as an outpatient procedure, which allows patients to go home the same day. This decreases the need for hospitalisation and helps women to return to their normal lives more rapidly. It also lowers the expense of healthcare associated with prolonged hospital stays.

For instance, according to the NCBI study published in August 2022, in the clinical trial conducted to test the safety and efficacy of the current device, a radiofrequency endometrial ablation device, 91% of the enrolled subjects reported no limitations in the device's activity, and 85% of the subjects were satisfied with the device's performance. Thus, the enhanced safety and efficacy of the radio frequency (RF) ablation system is likely to drive segment growth during the projection period.

Source: DataM Intelligence Analysis (2023)

Endometrial Ablation Devices Market Geographical Share

North America Accounted for Approximately 38.2% of the Market Share in 2022

North America is estimated to hold about 38.2% of the total market share throughout the forecast period throughout the projected period due to increased occurrences of gynaecological problems, expanding healthcare infrastructure, and the strong establishment of leading market players to provide novel endometrial ablation devices are responsible for driving the endometrial ablation devices market in this area.

For instance, endometriosis, a chronic inflammatory pain disorder, affects 6.5 million US women annually. The Canadian Cancer Society mentioned that around  1,450 Canadian women have been diagnosed with cervical cancer in 2022. The growing prevalence of endometritis and gynaecological disorders in the region is expected to drive demand for endometrial ablation devices, contributing to market growth in the region.

Source: DataM Intelligence Analysis (2023)

Endometrial Ablation Devices Market Companies

The major global players in the endometrial ablation devices market include Medtronic, Boston Scientific Corporation, Cooper Surgical, Minerva Surgical, Ethicon, KARL STORZ GmbH & Co. KG, Richard Wolf GmbH, AngioDynamics Inc., Smith & Nephew PLC, Olympus Corporation and others.

COVID-19 Impact Analysis

Russia Ukraine Conflict Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global endometrial ablation devices market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of endometrial ablation devices is expected to have little influence over the global endometrial ablation devices market growth over the forecast period.

By Device Type

• Hydrothermal ablators
• Thermal balloon ablators
• Hysteroscopy devices
• Cryoablation devices
• Radiofrequency endometrial ablation devices
• Microwave endometrial ablators
• Others

By End User

• Hospitals
• Ambulatory surgical centres
• Specialty Clinics
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• In April 2023, Hologic Inc, a medical technology firm largely focused on women's health, sells diagnostic, surgical, and medical imaging technologies. Its NovaSure V5 is a cutting-edge global endometrial ablation (GEA) device designed to assist surgeons in endometrial ablation treatments for the treatment of irregular uterine bleeding in women.
• In Oct 2023, Channel Medsystems Inc, a medical device company whose aim is to enable every woman to take charge of her health journey, announced that the current cryotherapy device was used for the first time in Europe to treat heavy menstrual bleeding (HMB). Fleur Bergwerff, M.D, performed the treatments at Bergman Specialty Clinics in Amsterdam, the Netherlands' biggest network of Specialty Clinics providing outpatient care and procedures to targeted medical experts and their patients.
• In Jan 2022 HystAR, a new high-fidelity hysteroscopy simulator from Inovus Medical, was announced. In order to provide extremely realistic, scalable, tracked hysteroscopy skills training, the simulator combines the company's unique augmented reality technology and cloud-based learning platform with the natural haptics of its synthetic tissue models.

Why Purchase the Report?

• To visualize the global endometrial ablation devices market segmentation based on device type, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the endometrial ablation devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global endometrial ablation devices report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies